Towa Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
8,702
15,206
9,903
7,237
9,833
18,886
Depreciation, Depletion & Amortization
5,407
5,724
7,329
7,980
8,173
8,340
Other Funds
3,033
5,057
3,266
121
1,316
5,358
Funds from Operations
11,076
15,873
13,966
15,094
19,325
21,867
Changes in Working Capital
2,932
7,836
10,234
4,899
95
2,865
Net Operating Cash Flow
8,144
8,037
3,732
10,195
19,230
19,002
Capital Expenditures
8,218
13,706
14,117
21,168
15,373
Sale of Fixed Assets & Businesses
3
1
1
682
1,522
Purchase/Sale of Investments
3,267
5,000
6,000
1,403
5,430
Net Investing Cash Flow
11,300
8,230
19,032
22,206
20,093
Cash Dividends Paid - Total
1,275
1,275
1,755
1,558
1,557
Issuance/Reduction of Debt, Net
4,804
1,513
34,767
1,467
6,229
Net Financing Cash Flow
3,529
238
27,970
92
4,670
Net Change in Cash
624
532
13,318
11,414
4,398
Free Cash Flow
190
5,284
9,822
10,293
4,754
Other Sources
182
475
1,084
-
111
Change in Capital Stock
-
-
5,042
-
-
Exchange Rate Effect
251
487
648
689
591
About Towa Pharmaceutical Co.
View Profile
